J. Scott International Introduces HPPA - Healthcare Policy & Program Analysis.

FORT WASHINGTON, Pa. -- J. Scott International, Inc. (JSI), a leading strategic healthcare research firm, announces the latest addition to its group of unique product offerings - Healthcare Policy & Program Analysis (HPPA).

Medicare Rx coverage has raised, and will continue to raise a number of issues and questions for patients, providers and the pharmaceutical industry. HPPA will explore the awareness and knowledge of the newly adopted policies or programs (federal and state) among affected consumers, providers and payers. It will also provide views and opinions on the plethora of programs that are or will be made available by private insurers, public assistance programs, pharmaceutical company programs, preliminary Medicare initiatives, and other efforts to reduce drug costs including the issue of drug re-importation.

Joy Scott, CEO of JSI, notes: "Seniors will have an array of options to choose from to attempt to minimize their drug costs. A major objective of HPPA is to provide actionable insights that will assist healthcare companies to maximize the benefits of programs, especially those under the Medicare Rx benefit."

By examining awareness and the behavioral characteristics of consumers, providers and payers, HPPA will identify sectors in which pharmaceutical companies can effectively contribute to consumer/provider understanding of programs and policies. The study's methodology will capture the thinking and actions of consumers/patients segmented by disease/condition, office-based physicians, high-volume independent and chain pharmacies, and managed care directors of major HMOs and PBMs.

"By addressing all of these targets, HPPA will be able to provide analyses of each segment as well as demonstrate where and how they are linked, thus providing a complete, and longitudinal view of marketplace dynamics," states Ms. Scott.

Initial fielding will take place in early Fall. To learn more about HPPA, or to schedule an in-depth presentation, please contact:

Michael J. DeCrescio
215-358-0800
[e-mail]

  Or

Ben D. Cohen
215-358-0800
[e-mail]

About J. Scott International, Inc.:

Other strategic services provided by J. Scott International include: Qualitative Detailing Analysis (QDA) which offers the pharmaceutical industry an unprecedented opportunity to qualitatively assess physician perceptions of the quality and impact of detailing efforts, Longitudinal Analysis-Patient Dialogue (LA-PD) designed to deliver an in-depth, critical look at how the individual patient experiences the treatment regimen - from symptom to outcome and all stages between, and Tracking Rx Influencers at the Point Of Dispensing (TRIPOD) which examines detailed insight into the drug dispensing dynamic. It discerns the nature and extent of the role that each key segment - Payers, Pharmacists, Patients and Physicians - plays in the ultimate dispensing decision, and qualitatively evaluates the rationale behind each segment's behavior. Joy Scott, CEO of J. Scott International, Inc. is a pioneer in the field of pharmaceutical market research. By anticipating key factors affecting the healthcare marketplace, she quickly developed a reputation for understanding her customer base and responding swiftly to meet the information needs of pharmaceutical company clients. Quality, value and unmatched customer service enabled Joy Scott to build one of the most successful market research firms in the United States.